Chongqing Lummy Pharmaceutical Co., Ltd.

Chongqing Lummy Pharmaceutical Co., Ltd.

Chongqing Lummy Pharmaceutical Co., Ltd.

Overview
Date Founded

1999

Headquarters

Chongqing Academy of Sci & Tech,2 Yangliu Road, Huangshan Avenue,16th Floor, New North Zone,Chongqing 401123

Type of Company

Public

Employees (Worldwide)

1,458

Industries

Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries

Company Description

Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical. Its products include tumor drugs, antibacterial drugs, antifungal drugs, antiviral agent, digestive system agents, immune system agents, blood system agents, cardiovascular system agents, nervous system agents, electrolyte and acid-base balance and nutritional, liver disease auxiliary drugs, endocrinology system drugs, Chinese patent drugs, base large infusion, American ginseng and active pharmaceutical ingredients. The company was founded on September 6, 1999 and is headquartered in Chongqing, China.

Website

www.cqlummy.com

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Yu Qiu

Chairman & President

Xue Feng Leng

Chief Financial Officer

Rong Fu

Deputy General Manager

Bin Zhao

Deputy General Manager

Dan Cui

Investor Relations Officer

Sun Zhang

Investor Relation

Board of Directors
Yu Qiu

Chairman & President at Chongqing Lummy Pharmaceutical Co., Ltd.

Xue Feng Leng

Chief Financial Officer at Chongqing Lummy Pharmaceutical Co., Ltd.

Xin Rong Zhang

Associate Professor at Chongqing Technology & Business University

Wei Jun Gu

Independent Director at Chongqing Lummy Pharmaceutical Co., Ltd.

Ying Wang

Director at Chongqing Lummy Pharmaceutical Co., Ltd.

Wei Qui

Director at Chongqing Lummy Pharmaceutical Co., Ltd.

Wei Dong Li

Trending People
H. C. Wainwright & Co. LLC
Daré Bioscience to Present at the H.C. Wainwright Global Life Sciences Conferenc... - GlobeNewswire
Dr. Seuss Enterprises LP
Six Dr. Seuss Books Will Stop Being Published Because of Racist Imagery - Time Magazine
Kohl's Corp.
Kohl's Should Reject Short-Sighted Activism - The Wall Street Journal
AB Volvo
How Green Are Electric Vehicles? - The New York Times
University of Illinois at Urbana-Champaign - College of Engineering
Intelligent.com Announces Best Graphic Design Degree Programs for 2021; Degree h... - PR Newswire
Trending Organizations
H. C. Wainwright & Co. LLC
Daré Bioscience to Present at the H.C. Wainwright Global Life Sciences Conferenc... - GlobeNewswire
Dr. Seuss Enterprises LP
Six Dr. Seuss Books Will Stop Being Published Because of Racist Imagery - Time Magazine
Kohl's Corp.
Kohl's Should Reject Short-Sighted Activism - The Wall Street Journal
AB Volvo
How Green Are Electric Vehicles? - The New York Times
University of Illinois at Urbana-Champaign - College of Engineering
Intelligent.com Announces Best Graphic Design Degree Programs for 2021; Degree h... - PR Newswire
Paths to Chongqing Lummy Pharmaceutical Co., Ltd.
Potential Connections via
Relationship Science
You
Chongqing Lummy Pharmaceutical Co., Ltd.
Recent Transactions
Details Hidden

Chongqing Lummy Pharmaceutical Co., Ltd. purchases Tibet Taida Housheng Pharmaceutical Co., Ltd. from Tibet Deyi Investment Management Co., Ltd.

Details Hidden

Chongqing Lummy Pharmaceutical Co., Ltd. purchases Chengdu Jinxing Health Pharmaceutical Co., Ltd. from Chengdu Jinxing Communications Group Co., Ltd.

Details Hidden

Chongqing Lummy Pharmaceutical Co., Ltd. purchases Chengdu Jinxing Sanum-kehlbeck Medicine Co. Ltd.

Transaction Advisors
Investment Advisor
Sinolink Securities Co., Ltd.

Advised onChongqing Lummy Pharmaceutical Co., Ltd. purchases Chongqing Lummy Heyuan Investment Co. Ltd. from Shanghai Liuhe Yuankui Investment Center LP, Shanghai Dingliang Heyuan Investment Center LP

Underwriter
Sinolink Securities Co., Ltd. (Broker)

Advised onChongqing Lummy Pharmaceutical Co., Ltd. issued A Shares

Investment Advisor
Tianfeng Securities Co., Ltd.

Advised onChongqing Lummy Pharmaceutical Co., Ltd. purchases Chongqing Lummy Heyuan Investment Co. Ltd. from Shanghai Liuhe Yuankui Investment Center LP, Shanghai Dingliang Heyuan Investment Center LP

Key Stats and Financials As of 2017
Market Capitalization
$3.49B
Total Enterprise Value
$5.72B
Earnings Per Share
$0.07
Revenue
$1.26B
Net Profit
$55.6M
Total Equity
$1.72B
EBITDAMargin
15.08%
Enterprise Value Sales
4.53x
EBITDA
$190M
Total Debt
$735M
Enterprise Value EBITDAOperating
30.05x
TEVNet Income
102.92x
Debt TEV
0.13x
Three Year Compounded Annual Growth Rate Of Revenue
11.59%
Five Year Compounded Annual Growth Rate Of Revenue
15.03%
Suppliers
Argos Therapeutics, Inc. Medical Support Services | Wilmington, DE

Argos Therapeutics, Inc. is a biopharmaceutical company, which engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. Its product candidates include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Ralph Steinman on May 8, 1997 and is headquartered in Durham, NC.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Chongqing Lummy Pharmaceutical Co., Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Chongqing Lummy Pharmaceutical Co., Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Chongqing Lummy Pharmaceutical Co., Ltd..